Table 1.
Treatment | Period1 | Effect on parenchyma | References |
---|---|---|---|
10% flaxseed | In utero (day 63 gestation to end lactation) | 31% ⬆ parenchymal weight | Farmer et al. (2007) |
2.3 g/d of genistein | 90 to 183 d | 44% ⬆ total DNA | Farmer et al. (2010) |
Ad libitum feeding vs. 25% feed restriction | 90 d to puberty | 46% ⬆ parenchymal weight | Sorensen et al. (2002b) |
Ad libitum feeding vs. 20% feed restriction | 90 d to puberty | 36% ⬆ parenchymal weight | Farmer et al. (2004) |
Ad libitum feeding vs. 33% feed restriction | 90 d to 5.5 mo | 52% ⬆ parenchymal weight 28% ⬆ total DNA |
Sorensen et al. (2006) |
24- vs. 36-mm BF2 at the end of gestation via changes in energy and protein intakes | Gestation | Approximately 240%⬆DNA concentrations | Head and Williams (1991) |
21- to 26- or 17- to 19-mm BF vs. 12- to 15-mm BF at the end of gestation via changes in feed intake | Gestation | Average of 33% ⬆ parenchymal weight | Farmer et al. (2016a) |
5.76 vs. 10.5 Mcal ME/d | Day 75 to end of gestation | 27% ⬆ parenchymal weight | Weldon et al. (1991) |
Domperidone (0.4 mg /kg BW) | Days 90 to 110 of gestation3 | 80% ⬆ in lumen diameter of mammary epithelial cells | VanKlompenberg et al. (2013) |
17.5 vs. 12 Mcal ME/d | Lactation | ⬆ parenchymal weight4 | Kim et al. (1999b) |
65 vs. 32 g lysine/d | Lactation | ⬆ parenchymal weight4 | Kim et al. (1999b) |
1Period where treatment was imposed.
2BF = backfat.
3Mammary development was not measured, but there was an increase in mammary epithelial cell differentiation.
4Percent increase could not be determined from the published data.